Cargando…
Increased Seroreactivity to Glioma-Expressed Antigen 2 in Brain Tumor Patients under Radiation
BACKGROUND: Surgery and radiation are the mainstays of therapy for human gliomas that are the most common primary brain tumors. Most recently, cell culture and animal studies provided the first convincing evidence that radiation not only eliminates tumor cells, but also modulates the immune response...
Autores principales: | Heisel, Sabrina M., Ketter, Ralf, Keller, Andreas, Klein, Veronika, Pallasch, Christian P., Lenhof, Hans-Peter, Meese, Eckart |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2008
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2366063/ https://www.ncbi.nlm.nih.gov/pubmed/18478111 http://dx.doi.org/10.1371/journal.pone.0002164 |
Ejemplares similares
-
SePaCS—a web-based application for classification of seroreactivity profiles
por: Keller, Andreas, et al.
Publicado: (2007) -
Novel autoantigens immunogenic in COPD patients
por: Leidinger, Petra, et al.
Publicado: (2009) -
A dictionary on microRNAs and their putative target pathways
por: Backes, Christina, et al.
Publicado: (2010) -
Autoantibody Signature Differentiates Wilms Tumor Patients from Neuroblastoma Patients
por: Schmitt, Jana, et al.
Publicado: (2011) -
Identification of lung cancer with high sensitivity and specificity by blood testing
por: Leidinger, Petra, et al.
Publicado: (2010)